L-Acetyl Carnitine HCl is a derivative of the amino acid carnitine, widely studied for its benefits in energy metabolism and cognitive support, especially in elderly individuals and those with certain health conditions. However, the use of L-Acetyl Carnitine HCl as a dietary supplement presents technical challenges, such as its particularly sour taste and high hygroscopicity, making it a difficult ingredient to work with, prone to clumping and aggregation.
Challenges in Formulating L-Acetyl Carnitine HCl
The hygroscopic nature of L-Acetyl Carnitine HCl can lead to moisture absorption and other aqueous components of the formulations, complicating the manufacturing process and the stability of the final product. These issues make the development of advanced formulation methods essential to ensure the effectiveness and manageability of the active ingredient.
IPS’s Solution: L-Acetyl Carnitine MATRIS®
To overcome these obstacles, IPS International Products & Services S.r.l. has developed L-Acetyl Carnitine MATRIS®, an innovative formulation that utilizes MATRIS® technology to mask the sour taste and significantly improve the product’s flowability on production lines. This technology not only facilitates the processing of the supplement but also enhances the end-consumer experience.
Proven Effects from Recent Studies
Recent studies conducted by IPS on 3D organoid systems have shown that L-Acetyl Carnitine HCl MATRIS® and Alpha Lipoic Acid MATRIS® alter the absorption kinetics of the actives, prolonging their half-life and significantly reducing levels of inflammation and sensitization at the gastric and intestinal levels. These studies have also shown that the absorption of MATRIS® products is superior to that of the pure ingredients, with significant benefits on the anti-inflammatory and antioxidant activity of the active ingredients. Furthermore, the combination of Carnitine and Alpha Lipoic Acid MATRIS® has demonstrated a synergistic effect in enhancing the anti-inflammatory and reparative efficacy of the peripheral nervous system.
Applications and Formulations
Thanks to the versatility of MATRIS® technology, L-Acetyl Carnitine MATRIS® can be formulated into various dosage forms, such as tablets, sachets, stick packs, capsules, and bottles with dosing caps, to meet diverse market and consumer needs.
SmarTTabs® for Perfect Compression
For applications requiring direct compression, IPS also offers SmarTTabs® formulations, which preserve the original release profile of the bulk active products. These formulations are ideal for maintaining the integrity and efficacy of the active ingredient throughout the absorption process.
Conclusion
L-Acetyl Carnitine MATRIS® by IPS represents a significant advancement in the field of dietary supplements, improving not only efficacy but also production convenience and consumer experience. With MATRIS® technology and SmarTTabs® formulations, IPS continues to lead in supplement innovation, effectively responding to the needs of a market increasingly focused on product quality and effectiveness.
Note: This article is provided for informational purposes only and does not substitute for professional medical advice.
